Search Results - "Montine, T"

Refine Results
  1. 1

    Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease by LI, G, LARSON, E. B, SONNEN, J. A, SHOFER, J. B, PETRIE, E. C, SCHANTZ, A, PESKIND, E. R, RASKIND, M. A, BREITNER, J. C. S, MONTINE, T. J

    Published in Neurology (28-08-2007)
    “…Treatment with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors ("statins") has been associated in some epidemiologic studies with reduced risk of…”
    Get full text
    Journal Article
  2. 2

    Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease by ZAJA-MILATOVIC, S, MILATOVIC, D, SCHANTZ, A. M, ZHANG, J, MONTINE, K. S, SAMII, A, DEUTCH, A. Y, MONTINE, T. J

    Published in Neurology (08-02-2005)
    “…Dysfunction of neostriatal medium spiny neurons (MSNs) is hypothesized to underlie late-stage motor complications of Parkinson disease (PD). The authors…”
    Get full text
    Journal Article
  3. 3

    Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies by Chibnik, L B, White, C C, Mukherjee, S, Raj, T, Yu, L, Larson, E B, Montine, T J, Keene, C D, Sonnen, J, Schneider, J A, Crane, P K, Shulman, J M, Bennett, D A, De Jager, P L

    Published in Molecular psychiatry (01-06-2018)
    “…Tauopathies, including Alzheimer’s disease (AD) and other neurodegenerative conditions, are defined by a pathological hallmark: neurofibrillary tangles (NFTs)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease by Kelly, V.E, Johnson, C.O, McGough, E.L, Shumway-Cook, A, Horak, F.B, Chung, K.A, Espay, A.J, Revilla, F.J, Devoto, J, Wood-Siverio, C, Factor, S.A, Cholerton, B, Edwards, K.L, Peterson, A.L, Quinn, J.F, Montine, T.J, Zabetian, C.P, Leverenz, J.B

    Published in Parkinsonism & related disorders (01-07-2015)
    “…Abstract Introduction Research suggests an association between global cognition and postural instability/gait disturbance (PIGD) in Parkinson disease (PD), but…”
    Get full text
    Journal Article
  6. 6

    Factors associated with resistance to dementia despite high Alzheimer disease pathology by ERTEN-LYONS, D, WOLTJER, R. L, DODGE, H, NIXON, R, VOROBIK, R, CALVERT, J. F, LEAHY, M, MONTINE, T, KAYE, J

    Published in Neurology (27-01-2009)
    “…Autopsy series have shown that some elderly people remain with normal cognitive function during life despite having high burdens of pathologic lesions…”
    Get full text
    Journal Article
  7. 7

    Neural transplantation in Huntington disease : Long-term grafts in two patients by KEENE, C. D, SONNEN, J. A, SWANSON, P. D, KOPYOV, O, LEVERENZ, J. B, BIRD, T. D, MONTINE, T. J

    Published in Neurology (12-06-2007)
    “…Clinical trials of fetal neural tissue transplantation for Huntington disease (HD) have been conducted with variable clinical results. However, no long-term…”
    Get full text
    Journal Article
  8. 8

    Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: Relevance to Parkinson's disease by ZHOU, Y, SHIE, F.-S, PICCARDO, P, MONTINE, T. J, ZHANG, J

    Published in Neuroscience (2004)
    “…Maneb, a widely used fungicide, has been associated with Parkinsonism in humans. In experimental models, maneb and its major active element, manganese…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology by Leverenz, J. B., Yu, C. E., Montine, T. J., Steinbart, E., Bekris, L. M., Zabetian, C., Kwong, L. K., Lee, V. M-Y., Schellenberg, G. D., Bird, T. D.

    Published in Brain (London, England : 1878) (01-05-2007)
    “…Mutations in the progranulin (GRN) gene have recently been reported as a cause of the frontotemporal dementia (FTD) syndrome. We performed a clinical,…”
    Get full text
    Journal Article
  11. 11

    Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques by SONNEN, J. A, LARSON, E. B, WALKER, R. L, HANEUSE, S, CRANE, P. K, GRAY, S. L, BREITNER, J. C. S, MONTINE, T. J

    Published in Neurology (28-09-2010)
    “…Observational and experimental studies suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) may protect against Alzheimer disease (AD); however, clinical…”
    Get full text
    Journal Article
  12. 12

    Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor by Savonenko, A., Munoz, P., Melnikova, T., Wang, Q., Liang, X., Breyer, R.M., Montine, T.J., Kirkwood, A., Andreasson, K.

    Published in Experimental neurology (01-05-2009)
    “…Cyclooxygenase-2 (COX-2) is a neuronal immediate early gene that is regulated by N-methyl d aspartate (NMDA) receptor activity. COX-2 enzymatic activity…”
    Get full text
    Journal Article
  13. 13

    Parkinson's Disease Is Associated with Oxidative Damage to Cytoplasmic DNA and RNA in Substantia Nigra Neurons by Zhang, Jing, Perry, George, Smith, Mark A., Robertson, David, Olson, Sandra J., Graham, Doyle G., Montine, Thomas J.

    Published in The American journal of pathology (01-05-1999)
    “…Oxidative damage, including modification of nucleic acids, may contribute to dopaminergic neurodegeneration in the substantia nigra (SN) of patients with…”
    Get full text
    Journal Article
  14. 14

    The Lipid Peroxidation Product 4‐Hydroxynonenal Inhibits Neurite Outgrowth, Disrupts Neuronal Microtubules, and Modifies Cellular Tubulin by Neely, M. D., Sidell, K. R., Graham, D. G., Montine, T. J.

    Published in Journal of neurochemistry (01-06-1999)
    “…: Oxidative stress is believed to be an important factor in the development of age‐related neurodegenerative diseases such as Alzheimer's disease (AD). The CNS…”
    Get full text
    Journal Article
  15. 15

    Elevated CSF prostaglandin E2 levels in patients with probable AD by MONTINE, T. J, SIDELL, K. R, CREWS, B. C, MARKESBERY, W. R, MARNETT, L. J, ROBERTS, L. J, MORROW, J. D

    Published in Neurology (22-10-1999)
    “…To determine CSF eicosanoid concentrations and brain cyclo-oxygenase activity in AD patients and age-matched control subjects. Nonsteroidal anti-inflammatory…”
    Get full text
    Journal Article
  16. 16

    Characterization of cognitive impairments and neurotransmitter changes in a novel transgenic mouse lacking Slc10a4 by Melief, E.J, Gibbs, J.T, Li, X, Morgan, R.G, Keene, C.D, Montine, T.J, Palmiter, R.D, Darvas, M

    Published in Neuroscience (02-06-2016)
    “…Highlights • Slc10a4 expression is enriched in midbrain and brainstem regions. • Slc10a4Δ/Δ mice have moderate impairment in spatial learning and cognitive…”
    Get full text
    Journal Article
  17. 17

    Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease by Montine, T J, Markesbery, W R, Morrow, J D, Roberts, 2nd, L J

    Published in Annals of neurology (01-09-1998)
    “…Postmortem studies have associated Alzheimer's disease (AD) with regionally increased oxidative damage to brain. Lacking, however, is a specific marker of…”
    Get more information
    Journal Article
  18. 18

    Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4 by Montine, KS, Olson, SJ, Amarnath, V, Whetsell, WO, Jr, Graham, DG, Montine, TJ

    Published in The American journal of pathology (01-02-1997)
    “…Cumulative oxidative damage, including lipid peroxidation, is a central component of cellular aging and is thought to play a role in the pathogenesis of…”
    Get full text
    Journal Article
  19. 19

    Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies by ZAJA-MILATOVIC, S, KEENE, C. D, MONTINE, K. S, LEVERENZ, J. B, TSUANG, D, MONTINE, T. J

    Published in Neurology (23-05-2006)
    “…Dementia with Lewy bodies (DLB) is the second most common form of dementia and shows more severely impaired performance on tests of executive functions…”
    Get full text
    Journal Article
  20. 20

    Increased CSF F2-isoprostane concentration in probable AD by MONTINE, T. J, BEAL, M. F, CUDKOWICZ, M. E, O'DONNELL, H, MARGOLIN, R. A, MCFARLAND, L, BACHRACH, A. F, ZACKERT, W. E, ROBERTS, L. J, MORROW, J. D

    Published in Neurology (01-02-1999)
    “…To quantify F2-isoprostane levels in CSF obtained from the lumbar cistern of patients with AD, ALS, and controls. Studies of human postmortem tissue and…”
    Get full text
    Journal Article